First Financial Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-14
Closed -$4.68K – 408
2024
Q3
$4.68K Hold
14
– – ﹤0.01% 349
2024
Q2
$3.82K Hold
14
– – ﹤0.01% 378
2024
Q1
$4.84K Buy
+14
New +$4.6K ﹤0.01% 416
2021
Q3
– Sell
-13
Closed -$8K – 348
2021
Q2
$8K Hold
13
– – 0.01% 313
2021
Q1
$7K Hold
13
– – ﹤0.01% 308
2020
Q4
$8K Buy
+13
New +$7.4K 0.01% 305

Other funds holding BIO

First Financial Corp's BIO Position: Q4 2024 in Review

First Financial Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2024, closing a stake of 14 shares — an estimated $4.68K sold.

First Financial Corp first reported a position in BIO in Q4 2020 and held it in 6 quarters. The position peaked at $8K in Q2 2021. 457 funds tracked by Wall St. Rank hold BIO as of Q4 2024.

  • First Financial Corp reported no remaining Bio-Rad Laboratories Class A position as of Q4 2024 after selling out during the quarter.
  • First Financial Corp sold 14 Bio-Rad Laboratories Class A shares in Q4 2024, an estimated $4.68K.
  • First Financial Corp first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and held it in 6 quarters.
  • First Financial Corp's Bio-Rad Laboratories Class A position peaked at $8K in Q2 2021.
  • 457 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2024.

Based on First Financial Corp's 13F filing for Q4 2024, filed 13 Jan 2025.